You are here

Pharmaceutical Approval Update: Oncology September 2006

Marvin M. Goldenberg, PhD, RPh, MS
PDF version: 
Dasatinib (Sprycel), bevacizumab plus IV 5-fluorouracil (Avastin), and topotecan injection (Hycamptin) plus cisplatin are discussed.